BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jerums G, Premaratne E, Panagiotopoulos S, Clarke S, Power DA, MacIsaac RJ. New and old markers of progression of diabetic nephropathy. Diabetes Res Clin Pract. 2008;82 Suppl 1:S30-S37. [PMID: 18937992 DOI: 10.1016/j.diabres.2008.09.032] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Gao C, Zhang W. Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy. Diabetes Res Clin Pract 2019;155:107805. [PMID: 31377226 DOI: 10.1016/j.diabres.2019.107805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29:1802-1809. [PMID: 21738053 DOI: 10.1097/hjh.0b013e3283495cd6] [Cited by in Crossref: 133] [Cited by in F6Publishing: 62] [Article Influence: 12.1] [Reference Citation Analysis]
3 Carlsson AC, Ingelsson E, Sundström J, Carrero JJ, Gustafsson S, Feldreich T, Stenemo M, Larsson A, Lind L, Ärnlöv J. Use of Proteomics To Investigate Kidney Function Decline over 5 Years. Clin J Am Soc Nephrol 2017;12:1226-35. [PMID: 28784837 DOI: 10.2215/CJN.08780816] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
4 Robles NR, Villa J, Gallego RH. Non-Proteinuric Diabetic Nephropathy. J Clin Med. 2015;4:1761-1773. [PMID: 26371050 DOI: 10.3390/jcm4091761] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
5 Bashier AM, Fadlallah AAS, Alhashemi N, Thadani PM, Abdelgadir E, Rashid F. Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus. Advances in Endocrinology 2015;2015:1-8. [DOI: 10.1155/2015/254042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
6 Moresco RN, Sangoi MB, De Carvalho JA, Tatsch E, Bochi GV. Diabetic nephropathy: traditional to proteomic markers. Clin Chim Acta. 2013;421:17-30. [PMID: 23485645 DOI: 10.1016/j.cca.2013.02.019] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
7 Cherney DZ, Sochett EB, Dekker MG, Perkins BA. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes. Diabet Med. 2010;27:1358-1365. [PMID: 21059087 DOI: 10.1111/j.1464-5491.2010.03121.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
8 Di Paolo S, Fiorentino M, De Nicola L, Reboldi G, Gesualdo L, Barutta F, Natali A, Penno G, Fioretto P, Pugliese G; Italian Society of Nephrology and the Italian Diabetes Society. Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society. Nutr Metab Cardiovasc Dis 2020;30:2123-32. [PMID: 33239162 DOI: 10.1016/j.numecd.2020.09.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Zürbig P, Jerums G, Hovind P, Macisaac RJ, Mischak H, Nielsen SE, Panagiotopoulos S, Persson F, Rossing P. Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes. 2012;61:3304-3313. [PMID: 22872235 DOI: 10.2337/db12-0348] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 16.4] [Reference Citation Analysis]
10 Li W, Wang J, Ge L, Shan J, Zhang C, Liu J. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy. Clin Exp Hypertens 2017;39:382-7. [PMID: 28513288 DOI: 10.1080/10641963.2017.1288739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
11 Piccoli GB, Grassi G, Cabiddu G, Nazha M, Roggero S, Capizzi I, De Pascale A, Priola AM, Di Vico C, Maxia S, Loi V, Asunis AM, Pani A, Veltri A. Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease. Rev Diabet Stud. 2015;12:87-109. [PMID: 26676663 DOI: 10.1900/rds.2015.12.87] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
12 Jerums G, Panagiotopoulos S, Premaratne E, MacIsaac RJ. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol 2009;5:397-406. [PMID: 19556994 DOI: 10.1038/nrneph.2009.91] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
13 Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metab Syndr 2009;1:10. [PMID: 19825147 DOI: 10.1186/1758-5996-1-10] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
14 Frankfurt JA, Duncan AF, Heyne RJ, Rosenfeld CR. Renal function and systolic blood pressure in very-low-birth-weight infants 1-3 years of age. Pediatr Nephrol 2012;27:2285-91. [PMID: 22832668 DOI: 10.1007/s00467-012-2265-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
15 Covington MD, Schnellmann RG. Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury. Kidney Int. 2012;81:391-400. [PMID: 22012129 DOI: 10.1038/ki.2011.356] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
16 Perkins BA, Sochett EB, Cherney DZ. Ability of Cystatin C to Detect Changes in Glomerular Filtration Rate After ACE Inhibition in Patients with Uncomplicated Type 1 Diabetes. Clinical and Experimental Hypertension 2012;34:606-11. [DOI: 10.3109/10641963.2012.681732] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Akman T, Binbay M, Aslan R, Yuruk E, Ozgor F, Tekinarslan E, Yazici O, Berberoglu Y, Muslumanoglu AY. Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single center experience. J Urol 2012;187:173-7. [PMID: 22099999 DOI: 10.1016/j.juro.2011.09.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
18 Simonson MS, Tiktin M, Debanne SM, Rahman M, Berger B, Hricik D, Ismail-Beigi F. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study. Am J Physiol Renal Physiol 2012;302:F820-9. [PMID: 22205226 DOI: 10.1152/ajprenal.00424.2011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
19 Dong Y, Wang WP, Lin P, Fan P, Mao F. Assessment of renal perfusion with contrast-enhanced ultrasound: Preliminary results in early diabetic nephropathies. Clin Hemorheol Microcirc 2016;62:229-38. [PMID: 26444598 DOI: 10.3233/CH-151967] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
20 Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Prašek M, Pavković P, Knotek M. Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria. Clin Biochem 2012;45:1694-6. [PMID: 22968085 DOI: 10.1016/j.clinbiochem.2012.07.115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
21 Di S, Han L, Wang Q, Liu X, Yang Y, Li F, Zhao L, Tong X. A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy. Evid Based Complement Alternat Med 2018;2018:7043402. [PMID: 30519269 DOI: 10.1155/2018/7043402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides. J Am Soc Nephrol 2015;26:1999-2010. [PMID: 25589610 DOI: 10.1681/ASN.2014050423] [Cited by in Crossref: 144] [Cited by in F6Publishing: 67] [Article Influence: 20.6] [Reference Citation Analysis]
23 Devetzis V, Daryadel A, Roumeliotis S, Theodoridis M, Wagner CA, Hettwer S, Huynh-Do U, Ploumis P, Arampatzis S. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics. PLoS One 2015;10:e0143524. [PMID: 26630274 DOI: 10.1371/journal.pone.0143524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
24 Meng H, Wu P, Zhao Y, Xu Z, Wang ZM, Li C, Wang L, Yang Z. Microalbuminuria in patients with preserved renal function as a risk factor for contrast-Induced acute kidney injury following invasive coronary angiography. Eur J Radiol 2016;85:1063-7. [PMID: 27161053 DOI: 10.1016/j.ejrad.2016.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Chien HY, Chen CY, Chiu YH, Lin YC, Li WC. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan. Int J Med Sci 2016;13:457-65. [PMID: 27279796 DOI: 10.7150/ijms.15548] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
26 Thomson HJ, Ekinci EI, Radcliffe NJ, Seah JM, MacIsaac RJ, Jerums G, Premaratne E. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes. J Diabetes Complications 2016;30:256-61. [PMID: 26794645 DOI: 10.1016/j.jdiacomp.2015.11.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
27 Yaribeygi H, Mohammadi MT. Evaluation of PPAR-α Agonist effect on Kidney Performance Through Increment of Nitric Oxide During Hyperglycemia-Induced Nephropathy in Rat. Razavi Int J Med 2016;4. [DOI: 10.17795/rijm37670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Lovrenčić MV, Biljak VR, Blaslov K, Božičević S, Duvnjak LS. Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. World J Diabetes 2017; 8(5): 222-229 [PMID: 28572883 DOI: 10.4239/wjd.v8.i5.222] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Akman T, Binbay M, Erbin A, Tepeler A, Sari E, Kucuktopcu O, Ozgor F, Muslumanoglu A. The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL). BJU Int. 2012;110:E1079-E1083. [PMID: 23046168 DOI: 10.1111/j.1464-410x.2012.11548.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
30 Tasić D, Radenkovic S, Stojanovic D, Milojkovic M, Stojanovic M, Ilic MD, Kocic G. Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes. Cardiorenal Med 2016;6:99-107. [PMID: 26989395 DOI: 10.1159/000437309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Kuo CC, Wu VC, Tsai CW, Wu KD; Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group). Relative kidney hyperfiltration in primary aldosteronism: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011;12:113-22. [PMID: 21436207 DOI: 10.1177/1470320310391331] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
32 Hermans MP, Ahn SA, Rousseau MF. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males. Cardiovasc Diabetol. 2010;9:88. [PMID: 21156040 DOI: 10.1186/1475-2840-9-88] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
33 El-Shewy HM, Sohn M, Wilson P, Lee MH, Hammad SM, Luttrell LM, Jaffa AA. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol 2012;26:833-45. [PMID: 22422617 DOI: 10.1210/me.2011-1261] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
34 Ngamdee T, Chalermwatanachai T, Siriwan C, Warachit O, Rijiravanich P, Surareungchai W. Target amplification-free detection of urinary microRNA for diabetic nephropathy diagnosis with electrocatalytic reaction. Anal Bioanal Chem 2022. [PMID: 35476120 DOI: 10.1007/s00216-022-04072-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wang C, Ma S, Deng B, Lu J, Shen W, Jin B, Shi H, Ding F. The predictive value of the product of contrast medium volume and urinary albumin/creatinine ratio in contrast-induced acute kidney injury. Ren Fail 2017;39:555-60. [PMID: 28726528 DOI: 10.1080/0886022X.2017.1349673] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]